The impact of the COVID-19 pandemic on drug demand and supply in Estonia

Authors

  • Katri Abel-Ollo National Institute for Health Development
  • Margo Kivila Police and Border Guard Board
  • Aljona Kurbatova National Institute for Health Development
  • Svetlana Ovsjannikova National Institute for Health Development

DOI:

https://doi.org/10.26881/jpgs.2022.1.03

Keywords:

COVID-19, drug demand, drug supply, service availability, Estonia

Abstract

The COVID-19 pandemic has changed the world and imposed restrictions and rules that democratic countries could not have foreseen. The global health and social care system was put under enormous pressure, and preventing it from a total collapse became the primary objective. This paper looks at how the pandemic affected the illicit drug market, people who use drugs and services designed to support and help them. Based on the available studies and administrative statistics from 2019 and 2020, illicit drug use and need for services remained the same despite the pandemic. Services quickly adopted new operating rules and became available for the target group. There is ample evidence that in some cases illicit drug use (e.g. cannabis) even gained in popularity as a coping method for anxiety and stress. The drug supply fell only temporarily due to the COVID-19, to which it quickly adapted through new IT and crypto possibilities (dark web).

Downloads

Download data is not yet available.

References

Abel-Ollo K., 2022, What lessons from Estonia’s experience could be applied in the US in response to the addiction and overdose crisis? Addiction [in press].

Abel-Ollo K., Riikoja A., Barndõk T., Kurbatova A., 2021a, Tallinna ja Pärnu reovee uuring uimastite jääkide suhtes 2020 (Eng. Wastewater study for drugs and their metabolic products in Tallinn and Pärnu 2020), Tervise Arengu Instituut, Tallinn.

Abel-Ollo K., Riikoja A., Barndõk T., Kurbatova A., Murd A., 2021b, Tallinna ja Narva linna kahjude vähendamise keskustes kogutavate süstalde uuring narkootikumide jääkide suhtes (Eng. Syringe residues analysis collected in harm reduction centers in Tallinn and Narva), Tervise Arengu Instituut, Tallinn.

EMCDDA, 2020, Trendspotter briefing. Impact of COVID-19 on drug services and help seeking in Europe, EMCDDA, Lisbon.

Estonian Forensic Science Institute, 2021, EMCDDA standard table 13: Number and quantity of seizures of illicit drugs. Estonian Police and Border Guard Board, 2021, EMCDDA standard table 16: Price of illicit substances (EUROS). Eurasian Harm Reduction Association, 2020, Harm reduction programmes during the COVID-19 crisis in Central and Eastern Europe and Central Asia, https://harmreductioneurasia.org/wp-content/uploads/2020/05/regional-review_- FINAL_ENG.pdf (accessed 03 May 2021).

Hollo V., Riikoja A., Barndõk T., Abel-Ollo K., Kurbatova A., 2020, Tallinna reovee uuring narkootiliste ja psühhotroopsete ainete jääkide suhtes (Eng. Wastewater study for drugs and their metabolic products in Tallinn), Tervise Arengu Instituut, Tallinn. Kütt V., 2020, Narkootikumide tarvitamine COVID-19 eriolukorra ajal (Eng. Drug use during COVID-19 restrictions), Tervise Arengu Instituut, Tallinn.

National Institute for Health Development, 2021a, Kahjude vähendamine (Eng. Harm reduction), Tervise Arengu Instituut, Tallinn. National Institute for Health Development, 2021b, Narkomaania ravi ja rehabilitatsioon (Eng. Drug treatment and rehabilitation), Tervise Arengu Instituut, Tallinn.

National Institute for Health Development, 2022. Narkootikumide üledoosist tingitud surmade ennetamise programm Eestis (Eng. Prevention program for drug related overdose deaths in Estonia). Tervise Arengu Instituut, Tallinn.

Penal Code. https://www.riigiteataja.ee/en/eli/ee/ 522012015002/consolide/current.

Raag M., Vorobjov S., Uusküla A., 2019, Prevalence of injecting drug use in Estonia 2010−2015: a capture-recapture study, Harm Reduction Journal, 16, 19. doi: 10.1186/ s12954-019-0289-3.

Reile R., Veideman T., 2021, Eesti täiskasvanud rahvastiku tervisekäitumise uuring 2020 (Eng. Estonian Adult Health Behavior Survey 2020), Tervise Arengu Instituut, Tallinn.

Salekešin M., Vorobjov S., 2019, HIV levimuse ja riskikäitumise uuring Narva narkootikume süstivate inimeste seas 2018 (Eng. Survey of risk behavior and HIV prevalence among PWID in Narva 2018), Tervise Arengu Instituut, Tallinn.

Salekešin M., Vorobjov S., 2021, HIVi levimuse ja riskikäitumise uuring narkootikume süstivate inimeste seas Kohtla-Järvel 2020 (Eng. Survey of risk behavior and HIV prevalence among PWID in Kohtla-Järvel 2020), Tervise Arengu Instituut, Tallinn.

Vorobjov S., Salekešin M., Vals K., 2019, Eesti täiskasvanud rahvastiku uimastite tarvitamise uuring (Eng. Estonian Adult Drug Use Survey 2019), Tervise Arengu Instituut, Tallinn.

Downloads

Published

2022-05-27

How to Cite

Abel-Ollo, K., Kivila, M., Kurbatova, A., & Ovsjannikova, S. (2022). The impact of the COVID-19 pandemic on drug demand and supply in Estonia. Journal of Geography, Politics and Society, 12(1), 8–16. https://doi.org/10.26881/jpgs.2022.1.03

Issue

Section

Articles